Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)Hedy L. Kindler, Richard M. Goldberg, Deborah Schrag et al.|Journal of Clinical Oncology|2010Cited by 840
Correlation of target kinase genotype with clinical activity of imatinib mesylate (IM) in patients with metastatic GI stromal tumors (GISTs) expressing KIT (KIT+)Michael C. Heinrich, Jonathan A. Fletcher, Jennifer Shoemaker et al.|Journal of Clinical Oncology|2005Cited by 64